Park Avenue Securities’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,724	Closed	-$2.68M	–	1723
2025 Q4	$2.68M	Sell	9,724 -188	-2%	-$51.4K	0.02%	447
2025 Q3	$2.6M	Sell	9,912 -973	-9%	-$236K	0.02%	491
2025 Q2	$2.38M	Sell	10,885 -272	-2%	-$58.1K	0.02%	462
2025 Q1	$2.5M	Buy	11,157 +2,440	+28%	+$672K	0.03%	344
2024 Q4	$2.85M	Buy	8,717 +1,222	+16%	+$385K	0.03%	362
2024 Q3	$2.25M	Sell	7,495 -654	-8%	-$200K	0.03%	402
2024 Q2	$2.68M	Buy	8,149 +466	+6%	+$165K	0.03%	334
2024 Q1	$3.04M	Buy	7,683 +291	+4%	+$108K	0.04%	293
2023 Q4	$2.6M	Sell	7,392 -154	-2%	-$54.5K	0.04%	305
2023 Q3	$2.83M	Buy	+7,546	New	+$2.92M	0.04%	247
2023 Q1	–	Sell	-7,739	Closed	-$1.82M	–	1173
2022 Q4	$1.82M	Sell	7,739 -1,085	-12%	-$257K	0.03%	333
2022 Q3	$2.17M	Sell	8,824 -1,500	-15%	-$457K	0.04%	249
2022 Q2	$3.12M	Sell	10,324 -900	-8%	-$293K	0.06%	192
2022 Q1	$4.61M	Buy	11,224 +548	+5%	+$215K	0.08%	136
2021 Q4	$5.01M	Buy	10,676 +1,085	+11%	+$467K	0.09%	126
2021 Q3	$4.07M	Sell	9,591 -323	-3%	-$136K	0.08%	122
2021 Q2	$3.56M	Buy	9,914 +1,865	+23%	+$616K	0.08%	138
2021 Q1	$2.27M	Buy	8,049 +1,457	+22%	+$417K	0.06%	181
2020 Q4	$1.87M	Buy	6,592 +920	+16%	+$258K	0.05%	167
2020 Q3	$1.56M	Buy	5,672 +863	+18%	+$228K	0.05%	159
2020 Q2	$1.09M	Buy	+4,809	New	+$945K	0.04%	182
2020 Q1	–	Sell	-2,622	Closed	-$394K	–	622
2019 Q4	$394K	Sell	2,622 -49	-2%	-$7.13K	0.02%	394
2019 Q3	$379K	Buy	+2,671	New	+$368K	0.02%	305
2019 Q2	–	Sell	-2,195	Closed	-$245K	–	485
2019 Q1	$245K	Buy	+2,195	New	+$228K	0.01%	382